Publication | Closed Access

Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients

Amyotrophic Lateral SclerosisNeurological DisorderCerebrospinal FluidCerebrospinal Fluid HomocysteineBlood-brain Barrier DisruptionNeurochemical BiomarkersBrain InjuryNeurologyNeuroscienceBrain PathologyCerebral Blood FlowMedicine